, Tracking Stock Market Picks
Enter Symbol:
Gilead Sciences, Inc. (GILD) [hlAlert]

up 31.66 %

Gilead Sciences, Inc. (GILD) upgraded to Outperform with price target $103 by Robert W. Baird

Posted on: Tuesday,  Feb 4, 2014  8:25 AM ET by Robert W. Baird

Robert W. Baird rated Outperform Gilead Sciences, Inc. (NASDAQ: GILD) on 02/04/2014, when the stock price was $82.02.
Since then, Gilead Sciences, Inc. has gained 31.66% as of 10/28/2015's recent price of $107.99.
If you would have followed this Robert W. Baird's recommendation on GILD, you would have gained 31.66% of your investment in 631 days.

Gilead Sciences, Inc. (Gilead) is a biopharmaceutical company that discovers, develops, and commercializes therapeutics in areas of unmet medical need. The Company has United States and international commercial sales operations, with marketing subsidiaries in Australia, Austria, Canada, France, Germany, Greece, Ireland, Italy, New Zealand, Portugal, Spain, Switzerland, Turkey, United Kingdom, and United States. Its commercial team promotes Truvada, Viread, Emtriva, Hepsera, AmBisome, Letairis, and Flolan through direct field contact with physicians, hospitals, clinics, and other healthcare providers. Gilead?s corporate partner, Astellas Pharma, Inc. (Astellas), promotes and sells AmBisome in the United States, Canada, Europe, Australia, and New Zealand. In May 2008, the Company acquired Navitas Assets, LLC?s. In April 2009, the Company announced the completion of its acquisition of CV Therapeutics, Inc.

Deep, comprehensive coverage is essential to your success. And with nearly 100 research professionals covering over 500 U.S. companies, our reputation for trusted, award-winning, in-depth analysis with a strong commitment to objective, fundamental research speaks for itself.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/4/2014 8:25 AM Buy
82.02 103.00
as of 10/17/2014
1 Week down  -2.87 %
1 Month down  -2.97 %
3 Months up  18.43 %
1 YTD up  22.83 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/26/2013 11:25 AM Hold
62.01 65.00
1/4/2013 8:25 AM Buy
37.64 43.00
9/12/2008 8:25 AM Buy
24.44 28.50
1/15/2008 8:25 AM Hold
23.90 24.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy